Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660984 · ClinicalTrials.gov registry record
Natural History Study of Children and Adults With Medullary Thyroid Cancer
A clinical trial of Medullary Thyroid Cancer, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 259
- Enrollment target
- 1
- Study location
NCT01660984 is a study of Medullary Thyroid Cancer that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 259 participants, below the 304-participant average among 4 other Medullary Thyroid Cancer trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01660984, a study of Medullary Thyroid Cancer, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 259 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it can cause a number of problems in addition to MTC. These problems include adrenal gland tumors, hormone changes, and problems with the bones and other organs. Not much is known about how MTC develops over time, especially in people with MEN2. Researchers want to study MTC in children and adults and see how it affects their growth and development. Objectives: \- To study how medullary thyroid cancer affects children and adults over time. Eligibility: \- Children and adults who have medullary thyroid cancer. Design: * Participants will be screened with a brief physical exam and medical history. Blood and tissue samples will be collected to see whether participants have the MEN2 genetic mutation. * Treatment will not be provided as part of this study. However, participants will be receiving standard care for MTC. They may be eligible for other clinical trials at the National Institutes of Health. * Participants will have regular study visits every 6 to 12 months to evaluate their MTC and any treatment. Blood tests, imaging studies, and other tests may be performed as needed to monitor the disease. * Participants and their parents/guardians will also complete questionnaires about their health and emotions during the study.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2012-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01660984
The ClinicalTrials.gov registry entry for NCT01660984 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 4 other Medullary Thyroid Cancer trials with a reported enrollment target (15% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Medullary Thyroid Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01660984 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01660984 about?
NCT01660984 is a clinical study titled "Natural History Study of Children and Adults With Medullary Thyroid Cancer". Background: \- Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it can cause a number of problems in addition to MTC. These pr...
What is the current status of trial NCT01660984?
This trial is currently recruiting. The enrollment target is 259 participants. The study started on 2012-07-30.
What conditions does trial NCT01660984 study?
This clinical trial studies the following conditions: Medullary Thyroid Cancer.
Who is sponsoring clinical trial NCT01660984?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01660984 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medullary Thyroid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
ACTIVE NOT RECRUITING · Phase 1
-
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.